
MedTech Actuator Accelerator - Meet Ruwini Cooray, Founder of Neurogen Global
MedTech Actuator Team
Through the MedTech Actuator Accelerator, Neurogen Global has made significant strides in developing a minimally invasive approach to treating neurological conditions.
The program provided access to clinical mentors, regulatory guidance, and investor networks that have been instrumental in advancing the technology toward pre-clinical trials. Ruwini joined the accelerator with a bold hypothesis and leaves with a validated pathway to commercialisation.
Image caption describing engaging visual goes here
Looking ahead, Neurogen Global is preparing for its first pre-clinical study in partnership with two leading Australian research institutions. The team is also in early conversations with strategic investors who specialise in neurotech and medical devices. MedTech Actuator continues to support the company through its alumni network and ongoing mentorship program.
Image 2 caption describing engaging visual goes here
MedTech Actuator continues to support the company through its alumni network and ongoing mentorship program. The program provided access to clinical mentors, regulatory guidance, and investor networks that have been instrumental in advancing the technology toward pre-clinical trials. Ruwini joined the accelerator with a bold hypothesis and leaves with a validated pathway to commercialisation.
Image caption describing engaging visual goes here

